Jerzy Gumulka
CIK: 0001793252
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNSP
CNS Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
About Gumulka Jerzy
Gumulka Jerzy (SEC CIK 0001793252) files insider reports with the SEC as Director of CNS Pharmaceuticals, Inc. (CNSP).
Signal8 holds 1 ownership filing by Gumulka Jerzy, a Form 4, filed on Nov 19, 2025. Those filings report 1 transaction, the latest on Nov 17, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Gumulka Jerzy's filings is in HOUSTON, TX.
Recent filings by Gumulka Jerzy
- Nov 17, 2025: Grant or award of CNSP derivative securities (Form 4, code A).
Other insiders filing for CNS Pharmaceuticals, Inc. (CNSP)
- Fisher Michal, Director
- Levin Rami, CEO and President
- Charles Faith L., Director
- Faulkner Eric, Chief Technology Officer
- O'Loughlin Steve, Chief Financial Officer
- Keyes Jeffry R., Director